Morning Overview on MSN
A single-shot gene-silencing therapy just cut dangerous cholesterol in half for a full year — built to replace the daily statins millions of adults already take
About half of all adults prescribed a statin stop taking it within a year. They forget, they dislike the side effects, or ...
Morning Overview on MSN
A single shot just slashed dangerous cholesterol levels for a full year in a late-stage trial — a gene-silencing therapy built to replace the daily statins millions take
For the roughly 200 million people worldwide who take a statin every day, the routine is deceptively simple: swallow a pill, ...
Longer-term follow-up of high-risk patients treated with inclisiran (Leqvio; Novartis) shows that the early reductions in LDL-cholesterol levels are sustained over several years, according to results ...
Cholesterol lowering with a strategy using the short interfering RNA agent, inclisiran, earlier in the treatment pathway led to significantly better long-term low-density lipoprotein (LDL) reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results